News Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Market Closed - Swiss Exchange Other stock markets 11:30:38 2024-04-18 am EDT			5-day change	1st Jan Change
41.95 ^CHF	+0.60%		+3.45%	+18.84%

Apr. 09	Basilea Pharmaceutica Receives Grant for Antibiotics Program	MT
Apr. 04	Stocks Close in Green as Swiss Inflation Unexpectedly Slows	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Basilea Pharmaceutica Receives Grant for Antibiotics Program	Apr. 09	MT
Basilea Pharmaceutica : Updated April 9, 2024	Apr. 09	PU
Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics	Apr. 09	GL
Stocks Close in Green as Swiss Inflation Unexpectedly Slows	Apr. 04	MT
European stocks rise ahead of inflation data; Basilea shines	Apr. 04	RE
Basilea Pharmaceutica : Updated April 4, 2024	Apr. 04	PU
Basilea announces US FDA approval of antibiotic ZEVTERA(R) (ceftobiprole medocaril) for three indications	Apr. 04	DJ
Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications	Apr. 04	GL
US FDA Greenlights Basilea Pharmaceutical's Treatment for Bloodstream Infections	Apr. 04	MT
US FDA approves Basilea Pharmaceutica's antibiotic	Apr. 03	RE
US FDA approves Basilea Pharmaceutica's antibiotic	Apr. 03	RE
Basilea Pharmaceutica : Updated April 3, 2024	Apr. 03	PU
Basilea Pharmaceutica to Receive Milestone Payment from Pfizer for Antifungal Drug	Mar. 11	MT
Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	Mar. 11	GL
Continued strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	Mar. 11	DJ
Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	Mar. 11	AQ
Stronger-than-Expected US Inflation Rate Weighs on Swiss Equities	Feb. 13	MT
Basilea Pharmaceutica AG Provides Earnings Guidance for the Year 2024	Feb. 13	CI
Transcript : Basilea Pharmaceutica AG, 2023 Earnings Call, Feb 13, 2024	Feb. 13
Basilea Pharmaceutica AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Summary

Filters